The complete absence of mammaglobin-A immunostaining in several important non-breast and non-gynecological cancer types that share histologic similarities with these tumors, such as adenocarcinomas from the gastrointestinal tract, pancreas, and lung, and cholangiocellular carcinomas, emphasizes the high diagnostic utility of mammaglobin-A immunohistochemistry if the clinical and morphological differential diagnosis includes gynecological tumors. The gene discussed is SCGB2A2; the disease is female reproductive organ cancer.